SciClone Biomedical Technology Co., Ltd. 2025 Q4 Financial Report
SciClone Biomedical Technology Co., Ltd. reported an operating revenue of 0.30 billion NTD and a net loss of 1.15 billion NTD for Q4 2025, with basic EPS at -1.89 NTD.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 21m after Collected)
Company Code: 6794 Company Name: SciClone Biomedical Technology Co., Ltd. Industry: Biotechnology and Medical Industry Year/Quarter: 2025 Q4 Basic Earnings Per Share: -1.89 NTD Operating Revenue: 0.30 billion NTD Net Income After Tax: -1.15 billion NTD